Vaxart stockholders urge stockholders to vote ‘AGAINST’ reverse stock split

Richard John Burgess, Daniel Houle, Michael Patrick Kelley, Marc Eustace Pereira, Patrice Raffy, Benjamin Sauv, Matthew M. Wallace, MD and David Whitney, who collectively beneficially own more than 2.5 million shares of Vaxart (VXRT), urged fellow stockholders to vote “AGAINST” the Company’s proposed reverse stock split at the upcoming special meeting of stockholders scheduled to be held on September 5, 2025. Despite clear and repeated stockholder opposition, the Company’s board of directors is once again seeking stockholder approval for a reverse stock split. At the Company’s June 13, 2025 annual meeting of stockholders, stockholders emphatically rejected a reverse stock split proposal and withheld support from a majority of the Board, including Chairman Dr. Michael Finney. Nevertheless, the full Board remains in place and is once again advancing a reverse stock split proposal, disregarding the will of stockholders.